Abstract
Lesch-Nyhan syndrome (LNS) is an X-linked recessive disorder that is transmitted by asymptomatic carrier females [1, 2]. Except for one case of a female with the LNS [3], in every family reported, transmission of the disease has been through the female to the affected male. The devastating neurological symptoms of this incurable disease makes its prevention of paramount importance. Prevention of LNS can be sought by means of detection of female carriers for hypoxanthine guanine phosphoribosyltransferase (HGPRT) deficiency and prenatal diagnosis. In families with one child or more affected by LNS, potential carriers must be screened for a deficient activity of HGPRT. The theoretical chance that a male fetus of a pregnant female carrier of LNS suffers the enzymatic defect is 50% and female carriers may ask for information about the risk of having offspring with this genetic disease. Antenatal diagnosis must be offered early because if an abortion is chosen it should take place at a stage of pregnancy when maternal — fetal bonding is less.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36: 561–570
Stout JT, Caskey CT (1989) Hypoxanthine phosphoribosyltransferase deficiency: the Leschnyhan syndrome and gouty arthritis. In: Scriver CR, Beaudet AL., Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1007–1028
Fujimoto WY, Seegmiller JE, Uhlendorf BW, et al (1968) Bichemical diagnosed of an X-linked disease in utero. Lancet ii; 511–512
Boyle JA, Raivio KO, Astrin KH, et al (1970) Lesch-Nyhan syndrome: preventative control by prenatal diagnosis. Science 169: 688–689
Crawhall JC, Henderson JF, Kelley WN (1972) Diagnosis and treatment of the Lesch-Nyhan syndrome. Pediatr Res 6: 504–513
De Bruyn CHMM. (1976) Hypoxanthine-guanine phosphoribosyltransferase deficiency in man. Hum Genet 31: 127–150
Gibbs DA, McFadyen IR, Crawfurd MDA, et al (1984) First trimester prenatal diagnosis of Lesch-Nyhan syndrome. Lancet ii: 1180–1183
Stout JT, Jackson LC, Caskey CT (1985) First trimester diagnosis of Lesch-Nyhan syndrome: application to other disorders of purine metabolism. Prenat Diagn 5: 183–189
Pai GS, Sprenke JA, Do TT, Mateni CE, Migeon RO (1980) Localization of loci for hypoxanthine phosphoribosyltransferase and glucose-6-phosphate dehydrogenase and biochemical evidence of non-random X-chromosome expression from human X-autosomal translocation. Proc Natl Acad Sci USA 77: 2810–2813
Singh S, Wilier I (1991) Biochemical and molecular genetic investigation of HPRT deficiency mutations in a Turkish and three German families: heterozygote, prenatal and postnatal diagnosis with cell culture, DNA blot and PCR technique (Abstract). Int J Purine Pyrimidine Res 2 (Suppl 1): 86
Mateos FA, Puig TH, Jiménez ML, Romera NM, Gonzáles A (1991) Prenatal diagnosis of Lesch-Nyhan syndrome by purine analysis of amniotic fluid and cordocentesis. Adv Exp Med Biol 309 B: 47–50
Valle D (1991) Treatment and prevention of genetic disorders. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdordorf RG, Martin JB, Fauci AS, Root RK (eds) Principles of internal medicine, 12th edn. McGraw-Hill, New York, pp 55–60
Gibs DA, Headhouse-Benson CM, Watts RWE (1986) Family studies of the Lesch-Nyhan syndrome: the use of restriction fragment length polymorphism ( RFLP) closely linked to the disease gene for carrier state and prenatal diagnosis. J Inher Dis 9: 45–58
Canadian Collaborative CVS-Amniocentesis Clinical Trial Group (1989) Multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Lancet i: 1–6
Rhoads GG, Jackson LG, Schlesselman SE, et al (1989) The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Eng J Med 320: 609–617
Gruber A, Zeitune M, Fejgin M (1989) Failure to diagnose Lesch-Nyhan syndrome by first trimester chorionic villus sampling. Prenat Diag 9: 452–453
Daffos F, Capella-Pavlovsky M, Forestier FA (1983) A new procedure for fetal blood sampling in utero: preliminary results of 53 cases. Am J Obstet Gynecol 146: 985–987
Seeds AE (1980) Current concepts of amniotic fluid dynamics. Am J Obstet Gynecol 138: 575–586
Fox IH (1985) Adenosine triphosphate degradation in specific disease. J Lab Clin Med 106: 101–110
Harkness RA (1989) Hypoxanthine, xanthine and uridine in body fluids, indicators of depletion. J Chromatogr Biom Appl 429: 255–278
Saugstad OD (1988) Hypoxanthine as an indicator of hypoxia. Its role in health and disease through free radical production. Pediatr Res 23: 143–150
Mateos FA, JG. Puig JG, Ramos TH, et al (1989) Erythrocyte ATP (iATP) as an indica¬tor of neonatal hypoxia. Adv Exp Med Biol 253A: 345–352
Aula P, Matilla K, Pironinen O, et al (1989) First trimester prenatal diagnosis of as-party lglucosaminuria. Prenat Diag 9: 617–620
Benn PA, Hsu LYF (1983) Maternal cell contamination of amniotic fluid cell cultures. Results of a US nationwide survey. Am J Med Genet 15: 297–305
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Verlag, Berlin Heidelberg
About this paper
Cite this paper
Mateos, F.A., Puig, J.G. (1993). Prenatal Diagnosis of Lesch-Nyhan Syndrome. In: Gresser, U. (eds) Molecular Genetics, Biochemistry and Clinical Aspects of Inherited Disorders of Purine and Pyrimidine Metabolism. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84962-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-84962-6_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84964-0
Online ISBN: 978-3-642-84962-6
eBook Packages: Springer Book Archive